Comparison of bevacizumab versus pemetrexed in combination with platinum-based doublets in first-line treatment of advanced non-small cell lung cancer.

被引：0
|
作者：
Rodrigues Pereira, Augusto Akikubo
Martins, Sandro Jose
Lessa, Rafael Costa
Ismael Pinto, Flavio Augusto
Gagliato, Debora De Melo
Santos, Elizabeth S.
Ferreira Rodrigues, Newton Augusto
Aires Freitas, Paulo Henrique
Padua, Fernando Vidigal
Alves, Marclesson S.
Lima, Geraldine Eltz
Fanelli, Marcello Ferretti
Rinck, Jose A.
Dettino, Aldo A.
Nicolau, Ulisses Ribaldo
Pereira, Jose Rodrigues
De Sousa Cruz, Marcelo Rocha
Lima, Vladmir C.
机构：
[1] Hosp AC Camargo Fund Antonio Prudente, Sao Paulo, Brazil
[2] Univ Brasilia, Brasilia, DF, Brazil
[3] Hosp AC Camargo Fund Antonio Prudente, Ctr Int Pesquisa & Ensino, Sao Paulo, Brazil
[4] AC Camargo, Sao Paulo, Brazil
[5] Inst Brasileiro Cancerol Torac, Sao Paulo, Brazil
[6] Hosp Sao Jose, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18078
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparison Of Bevacizumab Versus Pemetrexed In Combination With Platinum-based Doublets In First-line Treatment Of Advanced Non-small-cell Lung Cancer
    Pereira, A. A. R.
    Lessa, R. C.
    Martins, S. J.
    Pinto, F. A. I.
    Cruz, M. R. S.
    Pereira, J. R.
    Gagliato, D. M.
    Rodrigues, N. A. F.
    Santos, E. S.
    Lima, V. C. C.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S247 - S247
  • [2] Bevacizumab in combination with different platinum-based doublets in the first-line treatment for advanced nonsquamous non-small-cell lung cancer: A network meta-analysis
    Zhao, Shen
    Gao, Fangfang
    Zhang, Yaxiong
    Zhang, Zhonghan
    Zhang, Li
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (08) : 1676 - 1688
  • [3] Platinum doublets as first-line treatment for elderly patients with advanced non-small cell lung cancer
    Piacentini, Paolo
    Greco, Filippo
    Mercanti, Anna
    Trolese, Anna Rita
    Durante, Emilia
    Moratello, Giacomo
    Tognetto, Michele
    Furini, Lara
    Giuliani, Jacopo
    Bonetti, Andrea
    TUMORI JOURNAL, 2013, 99 (06): : 650 - 655
  • [4] Bevacizumab as first-line treatment for advanced non-small cell lung cancer
    Socinski, Mark A.
    DRUGS OF TODAY, 2008, 44 (04) : 293 - 301
  • [5] Comparison of the use of Platinum-Based Combination in the First and Second Line Treatment of Non-Small Cell Lung Cancer
    Yildirim, Mustafa
    Tildiz, Mustafa
    Goktas, Sevil
    Duman, Evrim
    Dilli, Utku Donem
    Parlak, Eda
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2013, 4 (05) : 390 - 393
  • [6] A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.
    Spigel, D. R.
    Greco, F. A.
    Shipley, D.
    Ervin, T. J.
    Lubiner, E. T.
    Peyton, J. D.
    Bames, E. K.
    Thompson, D. S.
    Burris, H. A., III
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Bevacizumab (Avastin) in Combination with Platinum-Based Chemotherapy as First-Line Therapy for Advanced Non-Small Cell Lung Cancer in Different Age Groups in Germany
    Wirtz, H.
    Lang, S.
    Gessner, C.
    Krueger, S.
    Zortel, M.
    Heinzmann, S.
    Schuette, W.
    PNEUMOLOGIE, 2020, 74 : S16 - S16
  • [8] Pemetrexed in first-line treatment of non-small cell lung cancer
    Esteban, Emilio
    Casillas, Marta
    Cassinello, Alejo
    CANCER TREATMENT REVIEWS, 2009, 35 (04) : 364 - 373
  • [9] Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancer
    Zhang Yi-fei
    Chen Zhi-wei
    Lu Shun
    CHINESE MEDICAL JOURNAL, 2009, 122 (20) : 2472 - 2476
  • [10] EFFECTIVENESS OF FIRST-LINE PEMETREXED PLUS PLATINUM FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
    Brandao, M. D. R. A.
    Luis, M. S.
    Amaral, N. C.
    Cassiano Neves, M.
    Camacho, C.
    Rodrigues, A. C.
    Pousa, I.
    Oliveira, J.
    Azevedo, I.
    ANNALS OF ONCOLOGY, 2015, 26
12345